http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20120019-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
filingDate 2011-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e94594cce3d90899d38a3c2aa6dc0b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0086a97a33f08c414bf1f1c8d4219b24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a82d700119605ee95aed5fa0d05fca8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d880a1c8571e777e0debb55645a3b5e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5236aadb7c4d94eb661fa5866e5499f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7ccd317e909beb248efd6d87fab7873
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0a6c7b551aebdf0ee220cf9e502d21e
publicationDate 2012-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20120019-A1
titleOfInvention COMBINATION OF PERINDOPRIL AND N - {[(7S) -3,4-DIMETOXIBICICLO [4.2.0] OCTA-1,3,5-TRIEN-7-IL] METIL} -3- (7,8-DIMETOXI-1, 2,4,5-TETRAHYDRO-3H-3-BENZAZEPIN-3-IL) -N-METHYL-3-OXO-1-PROPANAMINE
abstract REFERS TO A PHARMACEUTICAL COMPOSITION THAT INCLUDES: A) A SELECTIVE AND SPECIFIC INHIBITOR OF SINUS CURRENT If SUCH AS IVABRADINE IN THE FORM OF HYDROCHLORIDE OR N - {[(7S) -3,4-DIMETOXIBICICLO [4.2.0] OCTA-1 , 3,5-TRIEN-7-IL] METHYL} -3- (7,8-DIMETOXY-1,2,4,5-TETRAHYDRO-3H-3-BENZAZEPIN-3-IL) -N-METHYL-3- OXO-1-PROPANAMINE IN THE FORM OF HYDROCHLORIDE OR FUMARATE; AND B) AN INHIBITOR OF ANGIOTENSIN CONVERSION ENZYME SUCH AS PERINDOPRIL IN THE FORM OF A THIRD-BUTYLAMINE OR ARGININE SALT. SUCH COMPOSITION IS USEFUL IN THE TREATMENT OF HEART FAILURE WITH PRESERVED SYSTOLIC FUNCTION
priorityDate 2010-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID723
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107807

Total number of triples: 35.